The conflict has now reached a binary choice for investors. STAAR CEO Stephen Farrell warned that the activist is attempting ...

Bank of America has taken a sharper turn on Alcon , issuing a double downgrade that shifts the Swiss eye-care group from buy ...

The conflict has now reached a binary choice for investors. STAAR CEO Stephen Farrell warned that the activist is attempting ...

STAAR Surgical (STAA) dropped 5% after proxy adviser Glass Lewis recommended holders reject the revised $30.75 a share offer ...

Broadwood Partners, L.P. and its affiliates ("Broadwood" or "we") today announced that Glass, Lewis & Co., LLC ("Glass Lewis"), a leading independent proxy advisory firm, has reaffirmed its ...

The contested $1.6 billion merger of STAAR Surgical Company (NASDAQ:STAA) and Alcon AG (NYSE:ALC) escalated again today as ...

This week's Medtech in a Minute features news about Teleflex and an update on Alcon's efforts to buy Staar Surgical amid ...

Intro Paragraph** Alcon Inc. (NYSE: ALC) has recently encountered a shift in analyst sentiment, with Julien Ouaddour of BofA Securities downgrading the stock to “Underperform” as of. This rating ...

STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses (EVO ICL™) for vision correction, today issued the following statement to ...

Major STAAR shareholders reject Alcon's increased $30.75 bid, citing a flawed sale process, insufficient valuation, and ...

Alcon increases its acquisition offer for STAAR Surgical, emphasizing a final deal amid shareholder debates and delays in the ...